<DOC>
	<DOCNO>NCT00002720</DOCNO>
	<brief_summary>RATIONALE : Surgery remove axillary lymph node may effective treatment woman breast cancer . PURPOSE : Randomized phase III trial compare effectiveness therapy without axillary lymph node dissection follow quadrantectomy treat old woman stage I breast cancer estrogen receptor positive .</brief_summary>
	<brief_title>Surgery With Without Lymph Node Removal Treating Older Women With Stage I Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare efficacy quadrantectomy without axillary lymph node dissection , follow tamoxifen term local distant relapse rate overall survival patient stage I , invasive breast cancer . - Determine relationship biological variable , hormone receptor status , cell proliferation , DNA ploidy , clinical outcome disease patient . OUTLINE : This randomize , multicenter study . Patients stratify center . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo quadrantectomy dissection level I II axillary lymph node . - Arm II : Patients undergo quadrantectomy without axillary lymph node dissection . Patients arm receive tamoxifen daily 5 year . Patients follow every 4 month 2 year , every 6 month 2 year , annually thereafter . PROJECTED ACCRUAL : A total 642 patient accrue study within 3 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven stage I , invasive breast cancer Hormone receptor status : Estrogen receptor positive Progesterone receptor positive negative PATIENT CHARACTERISTICS : Age : 65 80 Sex : Female Menopausal status : Postmenopausal Performance status : Not specify Life Expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No serious disease would preclude surgery No prior concurrent malignancy except basal cell carcinoma carcinoma situ cervix PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2000</verification_date>
	<keyword>stage I breast cancer</keyword>
</DOC>